Results from our initial Rett's study must be out soon.
"Patient recruitment is expected to commence in early Q3 CY2023. The preliminary (top-line) results of the trial are anticipated in Q1 CY2024."
"If successful, the Company will follow with a 14-week double-blind, randomised, placebo-controlled Phase II in 34 participants to determine further efficacy and safety, which will require a separate HREC submission and approval."
GLTAH
I believe we are cheap -- Real cheap
Ann: NTI Receives HREC Approval for Rett Syndrome Clinical Trial, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
